Hi All,
We have just released our Quarterly Activity Report and Appendix 4C to the ASX for the period ending on 31 March 2022.
Highlights include:
• MagSense® HER2 breast cancer study interim results released during the quarter
• Move to new R&D facility completed
• Sponsored Research Agreement executed with researchers at Massachusetts General Hospital
Read the reports here: https://imagionbiosystems.com/news/quarterly-activity-report-and-appendix-4c-for-31-mar-2022/
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.677M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10941 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 305 | 1 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| IBX (ASX) Chart |
Day chart unavailable